Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calciphylaxis | 38 | 2024 | 130 | 12.810 |
Why?
|
Renal Dialysis | 30 | 2024 | 1799 | 3.860 |
Why?
|
Kidney Failure, Chronic | 36 | 2024 | 2495 | 3.760 |
Why?
|
Renal Insufficiency, Chronic | 22 | 2024 | 2310 | 3.010 |
Why?
|
Thiosulfates | 9 | 2020 | 52 | 2.440 |
Why?
|
Uremia | 5 | 2019 | 202 | 2.030 |
Why?
|
Hyponatremia | 7 | 2023 | 276 | 1.960 |
Why?
|
Nephrology | 5 | 2024 | 270 | 1.380 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1946 | 1.370 |
Why?
|
Hyperparathyroidism, Secondary | 4 | 2019 | 123 | 1.300 |
Why?
|
Olfaction Disorders | 2 | 2022 | 223 | 1.120 |
Why?
|
Skin Diseases | 5 | 2020 | 1088 | 1.050 |
Why?
|
Anemia, Sickle Cell | 5 | 2021 | 1067 | 1.030 |
Why?
|
Vitamin K | 2 | 2019 | 312 | 0.980 |
Why?
|
Leg Ulcer | 2 | 2019 | 70 | 0.890 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2023 | 17 | 0.870 |
Why?
|
Sickle Cell Trait | 3 | 2021 | 86 | 0.830 |
Why?
|
Taste Disorders | 1 | 2022 | 37 | 0.770 |
Why?
|
Hip Fractures | 4 | 2019 | 997 | 0.750 |
Why?
|
Hyperphosphatemia | 2 | 2023 | 38 | 0.710 |
Why?
|
Sodium | 3 | 2023 | 1591 | 0.660 |
Why?
|
Dialysis Solutions | 1 | 2019 | 33 | 0.660 |
Why?
|
Parathyroidectomy | 3 | 2019 | 244 | 0.640 |
Why?
|
Vitamin K Deficiency | 1 | 2019 | 24 | 0.630 |
Why?
|
Kidney Diseases | 10 | 2018 | 2098 | 0.610 |
Why?
|
Ergocalciferols | 3 | 2015 | 105 | 0.600 |
Why?
|
Arterioles | 2 | 2016 | 251 | 0.600 |
Why?
|
Hyperhomocysteinemia | 2 | 2016 | 117 | 0.600 |
Why?
|
Atrial Natriuretic Factor | 2 | 2009 | 348 | 0.590 |
Why?
|
Chelating Agents | 3 | 2020 | 380 | 0.580 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2009 | 193 | 0.570 |
Why?
|
Skin | 5 | 2020 | 4489 | 0.560 |
Why?
|
Vitamin B Complex | 2 | 2016 | 299 | 0.550 |
Why?
|
Carboxylic Acids | 1 | 2017 | 91 | 0.530 |
Why?
|
Hypotension | 1 | 2022 | 885 | 0.520 |
Why?
|
Potassium | 1 | 2019 | 1311 | 0.490 |
Why?
|
Folic Acid | 3 | 2016 | 1338 | 0.450 |
Why?
|
Humans | 124 | 2024 | 765968 | 0.450 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.440 |
Why?
|
Hospitalists | 2 | 2008 | 297 | 0.430 |
Why?
|
Randomized Controlled Trials as Topic | 19 | 2020 | 10383 | 0.430 |
Why?
|
Referral and Consultation | 6 | 2018 | 3615 | 0.420 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 42 | 0.410 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 833 | 0.400 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 844 | 0.400 |
Why?
|
Bone Diseases, Metabolic | 1 | 2016 | 407 | 0.390 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1077 | 0.390 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1030 | 0.380 |
Why?
|
Natriuretic Peptides | 2 | 2011 | 153 | 0.370 |
Why?
|
Middle Aged | 52 | 2024 | 223009 | 0.370 |
Why?
|
Dietary Supplements | 5 | 2022 | 3425 | 0.350 |
Why?
|
Serum Albumin | 2 | 2024 | 675 | 0.340 |
Why?
|
Thyroid Hormones | 1 | 2013 | 410 | 0.340 |
Why?
|
Osteoporosis | 4 | 2020 | 1582 | 0.330 |
Why?
|
Bone Density Conservation Agents | 4 | 2022 | 791 | 0.330 |
Why?
|
Vitamin D Deficiency | 3 | 2015 | 1348 | 0.330 |
Why?
|
Kidney Transplantation | 4 | 2019 | 4270 | 0.320 |
Why?
|
Male | 60 | 2024 | 363698 | 0.320 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2009 | 65 | 0.310 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2014 | 3251 | 0.310 |
Why?
|
Rare Diseases | 1 | 2014 | 635 | 0.310 |
Why?
|
Warfarin | 5 | 2023 | 1494 | 0.310 |
Why?
|
Diuretics | 1 | 2011 | 613 | 0.300 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2008 | 163 | 0.300 |
Why?
|
Premedication | 1 | 2009 | 244 | 0.290 |
Why?
|
Female | 61 | 2024 | 396112 | 0.290 |
Why?
|
Acetylcysteine | 1 | 2009 | 262 | 0.280 |
Why?
|
Aged | 40 | 2024 | 171117 | 0.280 |
Why?
|
Vitamin D | 4 | 2016 | 3272 | 0.270 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1959 | 0.270 |
Why?
|
Hydrothorax | 1 | 2006 | 20 | 0.270 |
Why?
|
Metabolic Diseases | 1 | 2013 | 687 | 0.260 |
Why?
|
Biopsy | 4 | 2020 | 6763 | 0.260 |
Why?
|
Risk Factors | 20 | 2024 | 74840 | 0.260 |
Why?
|
Atrial Fibrillation | 3 | 2018 | 5189 | 0.250 |
Why?
|
Gastric Bypass | 1 | 2014 | 820 | 0.250 |
Why?
|
Cause of Death | 7 | 2020 | 3708 | 0.240 |
Why?
|
Natural Language Processing | 1 | 2014 | 1203 | 0.240 |
Why?
|
Fibromuscular Dysplasia | 1 | 2005 | 56 | 0.240 |
Why?
|
Glomerular Filtration Rate | 8 | 2023 | 2233 | 0.240 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2008 | 290 | 0.240 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 15652 | 0.230 |
Why?
|
Diphosphonates | 2 | 2019 | 625 | 0.230 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3835 | 0.230 |
Why?
|
Polycythemia Vera | 1 | 2006 | 160 | 0.230 |
Why?
|
Inservice Training | 1 | 2006 | 375 | 0.220 |
Why?
|
Renal Artery | 1 | 2005 | 345 | 0.220 |
Why?
|
Vascular Diseases | 2 | 2022 | 1159 | 0.210 |
Why?
|
Metronidazole | 1 | 2004 | 236 | 0.210 |
Why?
|
Length of Stay | 4 | 2013 | 6485 | 0.210 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1292 | 0.210 |
Why?
|
Pyridones | 2 | 2018 | 816 | 0.210 |
Why?
|
Muscle Cramp | 1 | 2022 | 33 | 0.200 |
Why?
|
Rickets | 1 | 2023 | 66 | 0.200 |
Why?
|
Hypercalcemia | 2 | 2023 | 426 | 0.200 |
Why?
|
Homocysteine | 2 | 2016 | 638 | 0.200 |
Why?
|
Bone Density | 3 | 2020 | 3491 | 0.200 |
Why?
|
Hypophosphatemia | 1 | 2023 | 92 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2018 | 1514 | 0.190 |
Why?
|
Fanconi Syndrome | 1 | 2022 | 35 | 0.190 |
Why?
|
Databases, Factual | 4 | 2018 | 8067 | 0.190 |
Why?
|
Postoperative Complications | 4 | 2014 | 15747 | 0.190 |
Why?
|
Hospitalization | 2 | 2021 | 10808 | 0.190 |
Why?
|
International Classification of Diseases | 2 | 2019 | 935 | 0.190 |
Why?
|
Case-Control Studies | 7 | 2021 | 22223 | 0.180 |
Why?
|
Wound Healing | 2 | 2015 | 2792 | 0.180 |
Why?
|
Carnitine | 1 | 2022 | 253 | 0.180 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 62 | 0.180 |
Why?
|
Cohort Studies | 12 | 2024 | 41649 | 0.180 |
Why?
|
Venous Thrombosis | 3 | 2018 | 1327 | 0.180 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 452 | 0.170 |
Why?
|
Adult | 28 | 2024 | 223044 | 0.170 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12976 | 0.170 |
Why?
|
Anticoagulants | 4 | 2019 | 4862 | 0.170 |
Why?
|
Physician's Role | 1 | 2007 | 927 | 0.170 |
Why?
|
Peritoneal Neoplasms | 1 | 2006 | 703 | 0.170 |
Why?
|
Malnutrition | 2 | 2017 | 629 | 0.170 |
Why?
|
Fatal Outcome | 2 | 2015 | 1831 | 0.170 |
Why?
|
Smell | 1 | 2022 | 259 | 0.170 |
Why?
|
Blood Substitutes | 1 | 2019 | 57 | 0.160 |
Why?
|
Abdominal Pain | 1 | 2006 | 1069 | 0.160 |
Why?
|
Retrospective Studies | 22 | 2024 | 81514 | 0.160 |
Why?
|
Carbon-Carbon Ligases | 1 | 2019 | 19 | 0.160 |
Why?
|
Internal Medicine | 1 | 2006 | 1064 | 0.160 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 231 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2024 | 906 | 0.150 |
Why?
|
Vitamin K 1 | 1 | 2018 | 41 | 0.150 |
Why?
|
Prognosis | 9 | 2021 | 29922 | 0.150 |
Why?
|
Renal Replacement Therapy | 3 | 2010 | 281 | 0.150 |
Why?
|
Pyrazoles | 2 | 2018 | 2033 | 0.150 |
Why?
|
Hyperbaric Oxygenation | 1 | 2019 | 167 | 0.140 |
Why?
|
Pancreatitis | 1 | 2004 | 1087 | 0.140 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2021 | 399 | 0.140 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 187 | 0.140 |
Why?
|
Teriparatide | 1 | 2019 | 225 | 0.140 |
Why?
|
Alanine | 1 | 2020 | 612 | 0.140 |
Why?
|
Hydroxyurea | 1 | 2018 | 284 | 0.140 |
Why?
|
Theophylline | 1 | 2017 | 132 | 0.140 |
Why?
|
Bone and Bones | 2 | 2019 | 2554 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2022 | 1499 | 0.140 |
Why?
|
Professional Practice | 1 | 2019 | 313 | 0.130 |
Why?
|
Peritoneal Dialysis | 1 | 2017 | 161 | 0.130 |
Why?
|
Fractures, Bone | 2 | 2021 | 2041 | 0.130 |
Why?
|
General Practice | 1 | 2017 | 102 | 0.130 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2017 | 213 | 0.130 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 1707 | 0.130 |
Why?
|
Apatites | 1 | 2015 | 18 | 0.130 |
Why?
|
Cholesterol | 5 | 2014 | 2898 | 0.120 |
Why?
|
Debridement | 1 | 2018 | 495 | 0.120 |
Why?
|
Triglycerides | 4 | 2014 | 2441 | 0.120 |
Why?
|
Histone Deacetylases | 1 | 2019 | 708 | 0.120 |
Why?
|
Thrombophilia | 1 | 2018 | 308 | 0.120 |
Why?
|
Vitamin B 6 | 1 | 2016 | 238 | 0.120 |
Why?
|
Necrosis | 1 | 2019 | 1617 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2023 | 2354 | 0.120 |
Why?
|
Albuminuria | 1 | 2018 | 660 | 0.120 |
Why?
|
Recurrence | 2 | 2024 | 8501 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1206 | 0.120 |
Why?
|
Regenerative Medicine | 1 | 2018 | 303 | 0.120 |
Why?
|
Massachusetts | 4 | 2020 | 8875 | 0.110 |
Why?
|
Signal Transduction | 1 | 2017 | 23601 | 0.110 |
Why?
|
Electrolytes | 1 | 2015 | 280 | 0.110 |
Why?
|
Risk Assessment | 9 | 2021 | 24282 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1477 | 0.110 |
Why?
|
Crohn Disease | 1 | 2006 | 2283 | 0.110 |
Why?
|
Calcium | 2 | 2018 | 5767 | 0.110 |
Why?
|
Time Factors | 9 | 2019 | 40065 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2020 | 59489 | 0.110 |
Why?
|
Microvessels | 1 | 2018 | 591 | 0.110 |
Why?
|
Algorithms | 1 | 2014 | 14071 | 0.110 |
Why?
|
Leg | 1 | 2019 | 1080 | 0.110 |
Why?
|
Prevalence | 4 | 2024 | 15842 | 0.110 |
Why?
|
Chronic Disease | 5 | 2019 | 9347 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2023 | 997 | 0.110 |
Why?
|
Spectrum Analysis, Raman | 1 | 2015 | 252 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1511 | 0.100 |
Why?
|
Vitamin B 12 | 1 | 2016 | 532 | 0.100 |
Why?
|
Self Care | 1 | 2018 | 800 | 0.100 |
Why?
|
Parathyroid Hormone | 2 | 2017 | 1789 | 0.100 |
Why?
|
Nutritional Status | 2 | 2019 | 1620 | 0.100 |
Why?
|
Hypersensitivity | 1 | 2022 | 1168 | 0.100 |
Why?
|
Comorbidity | 6 | 2020 | 10563 | 0.100 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 1978 | 0.100 |
Why?
|
Fenoldopam | 1 | 2011 | 6 | 0.100 |
Why?
|
Diuretics, Osmotic | 1 | 2011 | 32 | 0.100 |
Why?
|
Minerals | 1 | 2013 | 278 | 0.090 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2011 | 77 | 0.090 |
Why?
|
Calcifediol | 1 | 2012 | 156 | 0.090 |
Why?
|
Medication Adherence | 2 | 2020 | 2192 | 0.090 |
Why?
|
Primary Health Care | 2 | 2007 | 4736 | 0.090 |
Why?
|
Age of Onset | 1 | 2018 | 3344 | 0.090 |
Why?
|
Perioperative Care | 2 | 2009 | 1055 | 0.090 |
Why?
|
Remission Induction | 2 | 2013 | 2411 | 0.090 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2011 | 157 | 0.090 |
Why?
|
Hypertension | 2 | 2022 | 8626 | 0.080 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 871 | 0.080 |
Why?
|
Substance-Related Disorders | 1 | 2006 | 4416 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2017 | 5343 | 0.080 |
Why?
|
Treatment Outcome | 12 | 2019 | 65188 | 0.080 |
Why?
|
Proteinuria | 2 | 2009 | 607 | 0.080 |
Why?
|
Incidence | 3 | 2018 | 21480 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6364 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2019 | 2968 | 0.080 |
Why?
|
Protein S Deficiency | 1 | 2008 | 13 | 0.080 |
Why?
|
Protein C Deficiency | 1 | 2008 | 25 | 0.080 |
Why?
|
Shock, Septic | 1 | 2015 | 774 | 0.080 |
Why?
|
Hyperlipidemias | 1 | 2013 | 770 | 0.080 |
Why?
|
Acute Disease | 2 | 2009 | 7232 | 0.080 |
Why?
|
Kidney | 3 | 2022 | 7066 | 0.080 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 969 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2334 | 0.070 |
Why?
|
Odds Ratio | 3 | 2009 | 9649 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15398 | 0.070 |
Why?
|
New York | 2 | 2007 | 880 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2012 | 550 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20124 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3432 | 0.070 |
Why?
|
Terminal Care | 1 | 2018 | 1774 | 0.070 |
Why?
|
Phosphorylation | 1 | 2017 | 8278 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3620 | 0.070 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2009 | 429 | 0.060 |
Why?
|
Internship and Residency | 1 | 2006 | 5946 | 0.060 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2008 | 157 | 0.060 |
Why?
|
Splenomegaly | 1 | 2006 | 192 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 349 | 0.060 |
Why?
|
Survival Analysis | 3 | 2021 | 10070 | 0.060 |
Why?
|
Catheters, Indwelling | 1 | 2007 | 438 | 0.060 |
Why?
|
Connective Tissue Diseases | 1 | 2008 | 284 | 0.060 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2004 | 28 | 0.060 |
Why?
|
United States | 5 | 2021 | 72903 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 2949 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9591 | 0.060 |
Why?
|
Prospective Studies | 6 | 2024 | 54802 | 0.060 |
Why?
|
Disease Progression | 5 | 2023 | 13632 | 0.060 |
Why?
|
Registries | 2 | 2018 | 8297 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5891 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6209 | 0.060 |
Why?
|
Aldosterone | 1 | 2009 | 881 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2019 | 3424 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 2010 | 728 | 0.050 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2780 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8041 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 830 | 0.050 |
Why?
|
Palliative Care | 1 | 2018 | 3645 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2007 | 384 | 0.050 |
Why?
|
Portal Vein | 1 | 2006 | 435 | 0.050 |
Why?
|
Respiration, Artificial | 2 | 2018 | 2709 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8529 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2009 | 2910 | 0.050 |
Why?
|
Creatinine | 1 | 2009 | 1915 | 0.050 |
Why?
|
Vaginosis, Bacterial | 1 | 2004 | 154 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8532 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2009 | 1061 | 0.050 |
Why?
|
Treatment Failure | 1 | 2009 | 2652 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4850 | 0.050 |
Why?
|
Hospitals, General | 1 | 2006 | 802 | 0.050 |
Why?
|
Dyslipidemias | 1 | 2009 | 869 | 0.050 |
Why?
|
Radiography, Abdominal | 1 | 2005 | 544 | 0.050 |
Why?
|
China | 2 | 2018 | 2385 | 0.050 |
Why?
|
Calcitriol | 1 | 2023 | 299 | 0.050 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2021 | 64 | 0.050 |
Why?
|
Primary Prevention | 1 | 2009 | 1187 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4335 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 293 | 0.040 |
Why?
|
Age Factors | 3 | 2018 | 18380 | 0.040 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 76 | 0.040 |
Why?
|
Myocardial Infarction | 3 | 2016 | 11499 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14652 | 0.040 |
Why?
|
India | 1 | 2006 | 2334 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1581 | 0.040 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 2 | 2009 | 29 | 0.040 |
Why?
|
Liver Transplantation | 2 | 2024 | 2412 | 0.040 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 114 | 0.040 |
Why?
|
Phosphates | 1 | 2023 | 763 | 0.040 |
Why?
|
Penis | 1 | 2020 | 209 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 1880 | 0.040 |
Why?
|
Administration, Oral | 2 | 2018 | 4015 | 0.040 |
Why?
|
Rats | 1 | 2015 | 23707 | 0.040 |
Why?
|
Neoplasms | 3 | 2022 | 22340 | 0.040 |
Why?
|
Animals | 4 | 2019 | 168764 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12509 | 0.040 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2022 | 702 | 0.040 |
Why?
|
Hip | 1 | 2019 | 249 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12795 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2018 | 67 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1377 | 0.040 |
Why?
|
Femur Neck | 1 | 2019 | 316 | 0.040 |
Why?
|
Stroke | 2 | 2018 | 9747 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18071 | 0.040 |
Why?
|
Health Resources | 1 | 2024 | 949 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 573 | 0.040 |
Why?
|
Heart Rate | 1 | 2009 | 4204 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1275 | 0.030 |
Why?
|
Hypolipidemic Agents | 2 | 2014 | 608 | 0.030 |
Why?
|
Injections | 1 | 2020 | 840 | 0.030 |
Why?
|
Quality of Life | 1 | 2018 | 13462 | 0.030 |
Why?
|
Drug Substitution | 1 | 2019 | 292 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2022 | 1178 | 0.030 |
Why?
|
Hyperkalemia | 2 | 2009 | 233 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3685 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 465 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2018 | 291 | 0.030 |
Why?
|
Hemorrhage | 2 | 2018 | 3461 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 254 | 0.030 |
Why?
|
Sodium Chloride, Dietary | 1 | 2018 | 303 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2019 | 577 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2018 | 493 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1709 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18293 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2018 | 683 | 0.030 |
Why?
|
Metagenomics | 1 | 2019 | 473 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8733 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2009 | 3985 | 0.030 |
Why?
|
Radiography | 1 | 2006 | 6919 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2018 | 655 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1043 | 0.030 |
Why?
|
Patient Discharge | 1 | 2007 | 3461 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26318 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5089 | 0.030 |
Why?
|
Sepsis | 1 | 2008 | 2606 | 0.030 |
Why?
|
Osteoporotic Fractures | 1 | 2019 | 415 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10603 | 0.030 |
Why?
|
Adolescent | 4 | 2018 | 88835 | 0.030 |
Why?
|
Curriculum | 1 | 2006 | 3782 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 962 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 13076 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1628 | 0.030 |
Why?
|
Spine | 1 | 2019 | 1128 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2013 | 281 | 0.030 |
Why?
|
Upper Extremity | 1 | 2018 | 682 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2018 | 803 | 0.020 |
Why?
|
Cost of Illness | 1 | 2022 | 1950 | 0.020 |
Why?
|
Consensus | 1 | 2022 | 3202 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2717 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14751 | 0.020 |
Why?
|
New England | 1 | 2015 | 1059 | 0.020 |
Why?
|
Aorta | 1 | 2019 | 2028 | 0.020 |
Why?
|
Abdomen | 1 | 2018 | 1134 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2015 | 1072 | 0.020 |
Why?
|
Critical Illness | 1 | 2024 | 2744 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 1002 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4908 | 0.020 |
Why?
|
Clinical Competence | 1 | 2006 | 4863 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3230 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15880 | 0.020 |
Why?
|
Lower Extremity | 1 | 2018 | 1226 | 0.020 |
Why?
|
Dopamine Agents | 1 | 2010 | 186 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2033 | 0.020 |
Why?
|
Saline Solution, Hypertonic | 1 | 2009 | 116 | 0.020 |
Why?
|
Graft Rejection | 2 | 2014 | 4499 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10729 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3050 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2564 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2010 | 988 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9338 | 0.010 |
Why?
|
Inflammation | 2 | 2017 | 10850 | 0.010 |
Why?
|
Renin-Angiotensin System | 1 | 2009 | 737 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39193 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11022 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14448 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4058 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12240 | 0.010 |
Why?
|
Heart Failure | 1 | 2007 | 11840 | 0.010 |
Why?
|
Child | 2 | 2023 | 80564 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4873 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2011 | 1393 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2009 | 1470 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16721 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22332 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59889 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12437 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12807 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16047 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 6309 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6322 | 0.010 |
Why?
|
Heart Diseases | 1 | 2010 | 2821 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36386 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42500 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12056 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81819 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27171 | 0.000 |
Why?
|